Title: Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure.

Authors: Debarba, L K; Mulka, A; Lima, J B M; Didyuk, O; Fakhoury, P; Koshko, L; Awada, A A; Zhang, K; Klueh, U; Sadagurski, M

Published In Brain Behav Immun, (2020 10)

Abstract: Benzene is a well-known human carcinogen that is one of the major components of air pollution. Sources of benzene in ambient air include cigarette smoke, e-cigarettes vaping, and evaporation of benzene containing petrol processes. While the carcinogenic effects of benzene exposure have been well studied, less is known about the metabolic effects of benzene exposure. We show that chronic exposure to benzene at low levels induces a severe metabolic imbalance in a sex-specific manner, and is associated with hypothalamic inflammation and endoplasmic reticulum (ER) stress. Benzene exposure rapidly activates hypothalamic ER stress and neuroinflammatory responses in male mice, while pharmacological inhibition of ER stress response by inhibiting IRE1α-XBP1 pathway significantly alleviates benzene-induced glial inflammatory responses. Additionally, feeding mice with Acarbose, a clinically available anti-diabetes drug, protected against benzene induced central and peripheral metabolic imbalance. Acarbose imitates the slowing of dietary carbohydrate digestion, suggesting that choosing a diet with a low glycemic index might be a potential strategy for reducing the negative metabolic effect of chronic exposure to benzene for smokers or people living/working in urban environments with high concentrations of exposure to automobile exhausts.

PubMed ID: 32505715

MeSH Terms: Acarbose; Animals; Benzene*; Electronic Nicotine Delivery Systems*; Endoribonucleases; Male; Mice; Protein-Serine-Threonine Kinases